» Articles » PMID: 20461783

The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity

Overview
Specialty Rheumatology
Date 2010 May 13
PMID 20461783
Citations 1287
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To develop simple, practical criteria for clinical diagnosis of fibromyalgia that are suitable for use in primary and specialty care and that do not require a tender point examination, and to provide a severity scale for characteristic fibromyalgia symptoms.

Methods: We performed a multicenter study of 829 previously diagnosed fibromyalgia patients and controls using physician physical and interview examinations, including a widespread pain index (WPI), a measure of the number of painful body regions. Random forest and recursive partitioning analyses were used to guide the development of a case definition of fibromyalgia, to develop criteria, and to construct a symptom severity (SS) scale.

Results: Approximately 25% of fibromyalgia patients did not satisfy the American College of Rheumatology (ACR) 1990 classification criteria at the time of the study. The most important diagnostic variables were WPI and categorical scales for cognitive symptoms, unrefreshed sleep, fatigue, and number of somatic symptoms. The categorical scales were summed to create an SS scale. We combined the SS scale and the WPI to recommend a new case definition of fibromyalgia: (WPI > or =7 AND SS > or =5) OR (WPI 3-6 AND SS > or =9).

Conclusion: This simple clinical case definition of fibromyalgia correctly classifies 88.1% of cases classified by the ACR classification criteria, and does not require a physical or tender point examination. The SS scale enables assessment of fibromyalgia symptom severity in persons with current or previous fibromyalgia, and in those to whom the criteria have not been applied. It will be especially useful in the longitudinal evaluation of patients with marked symptom variability.

Citing Articles

Short- and Medium-Term effects of major Ozone therapy on disease parameters in fibromyalgia syndrome: A retrospective study.

Usen A, Ozcan D, Agirman M, Guner H, Kocyigit B Rheumatol Int. 2025; 45(4):72.

PMID: 40072591 PMC: 11903636. DOI: 10.1007/s00296-025-05827-1.


Cerebrospinal fluid metabolomics, lipidomics and serine pathway dysfunction in myalgic encephalomyelitis/chronic fatigue syndroome (ME/CFS).

Baraniuk J Sci Rep. 2025; 15(1):7381.

PMID: 40025157 PMC: 11873053. DOI: 10.1038/s41598-025-91324-1.


Can Clinical, Psychological, and Cognitive Patient-Reported Outcome Measures (PROMs) Help to Discriminate Women with Fibromyalgia from Those with Other Localized/Regional Pain Conditions? A Diagnostic Accuracy Study.

Cigaran-Mendez M, Tejera-Alonso A, Gomez-Calero C, Fernandez-de-Las-Penas C, Lopez-Redondo M, Valera-Calero J Medicina (Kaunas). 2025; 61(2).

PMID: 40005475 PMC: 11857717. DOI: 10.3390/medicina61020359.


Exploring the TyG Index and the Homeostasis Model Assessment of Insulin Resistance as Insulin Resistance Markers: Implications for Fibromyalgia Management and Understanding-A Narrative Review.

Samavarchitehrani A, Mercantepe F, Behnoush A, Klisic A Diagnostics (Basel). 2025; 15(4).

PMID: 40002645 PMC: 11854647. DOI: 10.3390/diagnostics15040494.


Fibromyalgia and Inflammation: Unrevealing the Connection.

Garcia-Dominguez M Cells. 2025; 14(4).

PMID: 39996743 PMC: 11853252. DOI: 10.3390/cells14040271.